SANGAMO THERAPEUTICS
Live / Registered — Registered (as of 25 Nov 2025)
What this means for you
Registered since 25 Nov 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90420060
- Registration number
- 8042798
- Mark type
- Stylized text
- Filed
- 28 Dec 2020
- Published for opposition
- 28 Dec 2021
- Registered
- 25 Nov 2025
- Attorney of record
- R. Gwen Peterson
Goods and services
- Class 042 — Scientific and technological services: Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing
Owner
- Sangamo Therapeutics, Inc., Richmond, CA, US
- Sangamo Therapeutics, Inc., Richmond, CA, US
- Sangamo Therapeutics, Inc., Richmond, CA, US
Prosecution history
- 25 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 06 Nov 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Nov 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 Nov 2025 — ASSIGNED TO LIE
- 29 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Jul 2025 — NON-FINAL ACTION E-MAILED
- 29 Jul 2025 — SU - NON-FINAL ACTION - WRITTEN
- 14 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Feb 2025 — USE AMENDMENT FILED
- 14 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Feb 2025 — TEAS STATEMENT OF USE RECEIVED